1. Home
  2. RAPT vs HAIA Comparison

RAPT vs HAIA Comparison

Compare RAPT & HAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAPT
  • HAIA
  • Stock Information
  • Founded
  • RAPT 2015
  • HAIA 2021
  • Country
  • RAPT United States
  • HAIA United States
  • Employees
  • RAPT N/A
  • HAIA N/A
  • Industry
  • RAPT Biotechnology: Pharmaceutical Preparations
  • HAIA Blank Checks
  • Sector
  • RAPT Health Care
  • HAIA Finance
  • Exchange
  • RAPT Nasdaq
  • HAIA Nasdaq
  • Market Cap
  • RAPT 65.6M
  • HAIA 68.8M
  • IPO Year
  • RAPT 2019
  • HAIA 2021
  • Fundamental
  • Price
  • RAPT $1.52
  • HAIA $11.50
  • Analyst Decision
  • RAPT Hold
  • HAIA
  • Analyst Count
  • RAPT 10
  • HAIA 0
  • Target Price
  • RAPT $5.00
  • HAIA N/A
  • AVG Volume (30 Days)
  • RAPT 920.1K
  • HAIA 6.5K
  • Earning Date
  • RAPT 11-12-2024
  • HAIA 01-01-0001
  • Dividend Yield
  • RAPT N/A
  • HAIA N/A
  • EPS Growth
  • RAPT N/A
  • HAIA N/A
  • EPS
  • RAPT N/A
  • HAIA 0.13
  • Revenue
  • RAPT N/A
  • HAIA N/A
  • Revenue This Year
  • RAPT N/A
  • HAIA N/A
  • Revenue Next Year
  • RAPT N/A
  • HAIA N/A
  • P/E Ratio
  • RAPT N/A
  • HAIA $85.61
  • Revenue Growth
  • RAPT N/A
  • HAIA N/A
  • 52 Week Low
  • RAPT $1.25
  • HAIA $10.84
  • 52 Week High
  • RAPT $27.35
  • HAIA $11.53
  • Technical
  • Relative Strength Index (RSI)
  • RAPT 39.12
  • HAIA 64.85
  • Support Level
  • RAPT $1.31
  • HAIA $11.49
  • Resistance Level
  • RAPT $1.96
  • HAIA $11.52
  • Average True Range (ATR)
  • RAPT 0.37
  • HAIA 0.04
  • MACD
  • RAPT -0.09
  • HAIA 0.00
  • Stochastic Oscillator
  • RAPT 10.67
  • HAIA 83.81

About RAPT RAPT Therapeutics Inc.

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

About HAIA Healthcare AI Acquisition Corp.

Healthcare AI Acquisition Corp is a blank check company.

Share on Social Networks: